3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
4
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
11
Prostatic Neoplasms
10
Breast Neoplasms
8
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lung Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Renal Cell
3
Thrombocythemia, Essential
2
Testicular Neoplasms
2
Stomach Neoplasms
2
Skin Diseases
2
Primary Myelofibrosis
2
Polycythemia Vera
2
Myeloproliferative Disorders
2
Melanoma
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Hodgkin Disease
2
Hematologic Diseases
2
Glioma
2
Burkitt Lymphoma
2
Breast Neoplasms, Male
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Uveal Melanoma
1
Interventions
Surveys and Questionnaires
9
Cystectomy
6
Blood Specimen Collection
5
Neoadjuvant Therapy
4
Cystoscopy
4
Drug Therapy
3
avelumab
2
Urination
2
Urinary Diversion
2
Surgical Procedures, Operative
2
Radiotherapy
2
Pioglitazone
2
Microarray Analysis
2
Methods
2
Magnetic Resonance Spectroscopy
2
Interviews as Topic
2
Immunohistochemistry
2
Defecation
2
Biopsy
2
5-aminolevulinic acid hexyl ester
2
trastuzumab deruxtecan
1
sargramostim
1
pembrolizumab
1
erdafitinib
1
enfortumab vedotin
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Watchful Waiting
1
Urinary Sediment Analysis
1
Therapeutics
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Urinary Bladder Neoplasms
×
Watchful Waiting
×
Clear all
NCT02676180
2023-12-08
DETECT I
University College, London
Completed
3,700 enrolled